[Stem cells in cardiac patients]

Cuadros Celorrio M, Sarmiento Gonzalez-Nieto V, Villegas Portero R
Record ID 32011001515
Spanish
Authors' objectives: Research into cardiac insufficiency has been, and is, considered of maximum interest as it is one of the pathologies that represent a greater financial burden for Health Systems. This fact, among others, has allowed the development of promising treatments, such as cellular cardiomyoplasty that is able to regenerate cardiomyocytes and revascularize the infarcted area by means of the implantation of stem cells.Several studies have demonstrated that the infusion of stem cells in patients with cardiac ischaemia moderately improves the left ventricular function, although the number of patients, the heterogeneity of the trials, and the time of follow-up have not allowed a relationship to be made to a reduction of mortality and morbidity.The objective of this systematic review is to determine the effectiveness (analytical and clinical validity) of cellular cardiomyoplasty and its clinical utility, for its assessment by the National Health System of Spain.
Details
Project Status: Completed
URL for project: https://www.aetsa.org/publicacion/celulas-madre-en-pacientes-cardiacos/
Year Published: 2011
URL for published report: https://www.aetsa.org/download/publicaciones/antiguas/AETSA_2007-02-08_Celulas_Madre.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Heart Diseases
  • Stem Cell Transplantation
  • Stem Cells
Contact
Organisation Name: Andalusian Health Technology Assessment Area
Contact Address: Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name: aetsa.csalud@juntadeandalucia.es
Contact Email: aetsa.csalud@juntadeandalucia.es
Copyright: Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.